ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.695
      -0.11%
      Bitcoin
      64,842.39
      -0.45%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. AVEO Pharmaceuticals Inc (AVEO)

      7. AVEO Pharmaceuticals Inc (AVEO) News

      AVEO

      AVEO Pharmaceuticals (AVEO)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AVEO
      DateTimeSourceHeadlineSymbolCompany
      11/07/20197:00AMBusiness WireAVEO Oncology & Biodesix Announce Initiation of the CyFi-2 Study, a Phase 2 Randomized Study of Ficlatuzumab in Combination w...NASDAQ:AVEOAVEO Pharmaceuticals Inc
      11/05/20197:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      11/04/20197:00AMBusiness WireAVEO Oncology Announces Regulatory Update for Tivozanib in Renal Cell CarcinomaNASDAQ:AVEOAVEO Pharmaceuticals Inc
      10/03/20199:12AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      09/30/20197:00AMBusiness WireAVEO Oncology Announces Initiation of Enrollment in Phase 1b/2 Study of FOTIVDA® (tivozanib) in Combination with IMFINZI® (...NASDAQ:AVEOAVEO Pharmaceuticals Inc
      09/27/20197:24AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      09/26/20197:00AMBusiness WireAVEO Oncology to Present at the 2019 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:AVEOAVEO Pharmaceuticals Inc
      09/23/20197:00AMBusiness WireAVEO Oncology & EUSA Pharma Announce Presentation of Final PFS Results from Phase 2 Portion of the TiNivo Study in Renal Cell...NASDAQ:AVEOAVEO Pharmaceuticals Inc
      09/17/20195:23PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      09/12/20194:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      09/10/20199:44AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      09/10/20196:30AMBusiness WireAVEO Oncology Announces Updated Overall Survival Hazard Ratio of 0.99 in Phase 3 TIVO-3 Trial of Tivozanib in Renal Cell Carc...NASDAQ:AVEOAVEO Pharmaceuticals Inc
      08/27/20195:26PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      08/08/20194:05PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      08/08/20197:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      08/08/20197:00AMBusiness WireAVEO Reports Second Quarter 2019 Financial Results and Provides Business UpdateNASDAQ:AVEOAVEO Pharmaceuticals Inc
      08/01/20196:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      08/01/20196:00AMBusiness WireKyowa Kirin Buys Back Tivozanib Non-Oncology Rights from AVEO OncologyNASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/14/20198:03AMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/13/20195:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/13/20195:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/13/20195:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      06/13/20194:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/31/20195:12PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/29/20197:00AMBusiness WireAVEO Oncology to Present at the 2019 BIO International ConventionNASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/15/20195:00PMBusiness WireAVEO Oncology Announces Presentations at the 2019 ASCO Annual MeetingNASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/10/20191:42PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/09/20194:06PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/09/20197:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      05/09/20197:00AMBusiness WireAVEO Reports First Quarter 2019 Financial Results and Provides Business UpdateNASDAQ:AVEOAVEO Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:AVEO